[Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation]

Roxolyana Abdah-Bortnyak; Zvi Bernstein; Nijm Ramon; Daniela Zalman; Julia Shnaider; Abraham Kuten

[Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation]

Harefuah. 2007 Feb;146(2):126-8, 164-5.

[Article in Hebrew]

Authors

Roxolyana Abdah-Bortnyak¹, Zvi Bernstein, Nijm Ramon, Daniela Zalman, Julia Shnaider, Abraham Kuten

Affiliation

¹ Oncology Department, Rambam Medical Center, Haifa. l_abdach@rambam.health.gov.il

PMID: 17352282

Abstract

Gynecomastia is a benign condition characterized by proliferation of mammary glandular tissue. Hormonotherapy with bicalutamide for prostate cancer is one of the causes of gynecomastia. The well known aim of treatment is to decrease psychological distress and to improve cosmetic appearance. Prophylactic breast irradiation may prevent the appearance of gynecomastia.

Publication types

English Abstract
Review

MeSH terms

Androgen Antagonists / adverse effects*
Anilides / adverse effects*
Breast / radiation effects*
Gynecomastia / chemically induced*
Gynecomastia / prevention & control
Humans
Male
Nitriles / adverse effects*
Prostatic Neoplasms / drug therapy*
Tosyl Compounds / adverse effects*

Substances

Androgen Antagonists
Anilides
Nitriles
Tosyl Compounds
bicalutamide